Johnson & Johnson (JNJ) Position Decreased by Retirement Systems of Alabama

Retirement Systems of Alabama lowered its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.3% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,805,559 shares of the company’s stock after selling 5,466 shares during the period. Johnson & Johnson makes up approximately 1.3% of Retirement Systems of Alabama’s investment portfolio, making the stock its 9th largest position. Retirement Systems of Alabama owned 0.07% of Johnson & Johnson worth $238,857,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Lenox Wealth Advisors Inc. boosted its position in shares of Johnson & Johnson by 0.6% during the 2nd quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock worth $116,000 after purchasing an additional 5 shares during the period. Harel Insurance Investments & Financial Services Ltd. boosted its position in Johnson & Johnson by 241.0% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,190 shares of the company’s stock valued at $149,000 after buying an additional 841 shares during the period. Ullmann Financial Group Inc. purchased a new position in Johnson & Johnson in the 1st quarter valued at approximately $186,000. Taylor Wealth Management Partners boosted its position in Johnson & Johnson by 19.8% in the 1st quarter. Taylor Wealth Management Partners now owns 1,510 shares of the company’s stock valued at $188,000 after buying an additional 250 shares during the period. Finally, Puplava Financial Services Inc. purchased a new position in Johnson & Johnson in the 2nd quarter valued at approximately $202,000. 65.93% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This piece was reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.themarketsdaily.com/2017/11/14/johnson-johnson-jnj-position-decreased-by-retirement-systems-of-alabama.html.

Several equities analysts have commented on the stock. Credit Suisse Group reissued a “buy” rating on shares of Johnson & Johnson in a research report on Friday, August 4th. Piper Jaffray Companies reissued a “hold” rating and issued a $120.00 price target on shares of Johnson & Johnson in a research report on Wednesday, October 4th. Vetr cut shares of Johnson & Johnson from a “hold” rating to a “sell” rating and set a $130.49 price target for the company. in a research report on Monday, September 18th. Alembic Global Advisors cut shares of Johnson & Johnson from a “neutral” rating to an “underweight” rating in a research report on Friday, July 21st. Finally, Stifel Nicolaus lifted their price objective on shares of Johnson & Johnson from $140.00 to $142.00 and gave the stock a “hold” rating in a research report on Wednesday, October 18th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $143.70.

Johnson & Johnson (JNJ) opened at $139.76 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.32 and a debt-to-equity ratio of 0.36. The company has a market cap of $374,930.72, a price-to-earnings ratio of 19.55, a price-to-earnings-growth ratio of 2.84 and a beta of 0.82. Johnson & Johnson has a one year low of $109.32 and a one year high of $144.35.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. The company had revenue of $19.65 billion for the quarter, compared to analyst estimates of $19.29 billion. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. Johnson & Johnson’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.68 earnings per share. equities research analysts anticipate that Johnson & Johnson will post 7.28 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 28th will be paid a $0.84 dividend. The ex-dividend date of this dividend is Monday, November 27th. This represents a $3.36 dividend on an annualized basis and a yield of 2.40%. Johnson & Johnson’s dividend payout ratio is presently 58.33%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply